XRHealth has acquired NeuroReality, including its flagship product "Koji's Quest" to further establish its position as a leading XR therapeutic platform. This acquisition follows XRHealth's purchase of Amelia Virtual Care and enhances its suite of therapeutic offerings for physical, emotional, and cognitive rehabilitation through immersive XR experiences. CEO Eran Orr described the acquisition as a step towards providing a more comprehensive XR platform for patients and clinicians.
‍
XRHealth's mission is to revolutionize healthcare by combining AI-powered XR technology with clinical expertise, supporting a range of therapies and expanding accessibility to digital health solutions worldwide, says a press release.
‍
"Koji's Quest" offers users unique interactive experiences designed to aid in physical, emotional, and cognitive rehabilitation, making it a valuable addition to XRHealth's platform. By integrating "Koji's Quest" into its suite of offerings, XRHealth is expanding the ways healthcare providers can engage patients in their therapeutic journeys, using VR and XR to support better health outcomes across a broad range of conditions.
‍
"The acquisition of NeuroReality and its flagship product, Koji's Quest, represents another leap forward in our mission to provide the most comprehensive XR therapeutic platform available." – Eran Orr, CEO of XRHealth.
‍
Related The AI Multidisciplinary XR Therapeutic Platform
‍
Eran Orr, CEO of XRHealth, expressed his enthusiasm for the acquisition: "The acquisition of NeuroReality and its flagship product, Koji's Quest, represents another leap forward in our mission to provide the most comprehensive XR therapeutic platform available. We are focused on creating a transformative experience for patients and clinicians alike, and Koji's Quest will allow us to offer an even richer, more engaging set of tools for therapy and rehabilitation."
The addition of "Koji's Quest" underscores XRHealth's commitment to advancing the accessibility and effectiveness of XR therapies, setting the stage for even more impactful innovations in digital healthcare.
‍
About XRHealth
‍
XRHealth is a leading provider of AI-powered, immersive healthcare solutions, leveraging extended reality (XR) technology to transform patient care and rehabilitation. With a mission to enhance medical treatments and improve patient outcomes, XRHealth offers an advanced platform supporting various applications, including physical therapy, cognitive rehabilitation, pain management, and mental health. In addition to developing cutting-edge technology, XRHealth operates its own clinics and collaborates with healthcare organizations worldwide, enabling seamless integration of XR therapies into diverse clinical settings. Following the acquisition of Amelia Virtual Care, XRHealth has expanded its mental health expertise, further advancing the accessibility and effectiveness of digital healthcare solutions. With a unique blend of AI-driven insights and clinical expertise, XRHealth is at the forefront of the digital health revolution, empowering patients and healthcare providers globally.

Researchers at Carnegie Mellon University's Human-Computer Interaction Institute developed a tool that uses AI to control AR/VR interfaces by touching your skin with a finger.
‍
The team wanted to ultimately design a control that would provide tactile feedback using only the sensors that come with a standard AR/VR headset. OmniTouch, a previous method developed by Chris Harrison, an associate professor in the HCII and director of the Future Interfaces Group, got close. But that method required a special, clunky, depth-sensing camera. Vimal Mollyn, a Ph.D. student advised by Harrison, had the idea to use a machine learning algorithm to train normal cameras to recognize touching, reports Charlotte Hu at Carnegie Mello University.
‍
"Try taking your finger and see what happens when you touch your skin with it. You'll notice that there are these shadows and local skin deformations that only occur when you're touching the skin," Mollyn said. "If we can see these, then we can train a machine learning model to do the same, and that's essentially what we did."
Mollyn used a special touch sensor that went along the palm and underneath of the index finger to gather data for EgoTouch. While remaining undetectable to the camera, the sensor gathered information on various touch kinds at various forces. Without human annotation, the model then learned to associate skin abnormalities and shadows to touch and force. The team collected hours of data in a variety of scenarios, activities, and lighting settings, expanding its training data collection to include 15 individuals with varying skin tones and hair densities.
‍
Related Wearable Ring Turns Any Surface into Touchpad
‍
EgoTouch can detect touch with more than 96% accuracy and has a false positive rate of around 5%. It recognizes pressing down, lifting up and dragging. The model can also classify whether a touch was light or hard with 98% accuracy.
‍
"That can be really useful for having a right-click functionality on the skin," Mollyn said.
‍
Developers may be able to imitate touchscreen gestures on our skin by detecting changes in touch. For instance, your smartphone can detect when you tap and hold an icon, zoom in, swipe right, or scroll up or down a page. The camera must be able to distinguish the minute variations between touch type and force in order to convert this into a skin-based interface.
‍
Across a range of skin tones and hair densities, as well as at various locations on the hand and forearm, such as the palm, back, and front of the arm, the accuracy was roughly the same. Bony regions such as the knuckles were not effectively served by the system.
"It's probably because there wasn't as much skin deformation in those areas," Mollyn said. "As a user interface designer, what you can do is avoid placing elements on those regions."
‍
Mollyn is exploring ways to use night vision cameras and nighttime illumination to enable the EgoTouch system to work in the dark. He's also collaborating with researchers to extend this touch-detection method to surfaces other than the skin.
"For the first time, we have a system that just uses a camera that is already in all the headsets. Our models are calibration free, and they work right out of the box," said Mollyn. "Now we can build off prior work on on-skin interfaces and actually make them real."

Kubota’s latest innovation in robotics, the KATR, is an all-terrain robot. It has made the papers in both the industrial and agricultural sectors. This robot can seamlessly operate in uneven and challenging terrains. For this, it has been recognized at the CES 2025 Innovation Awards.
‍
The KATR has a unique design where its wheels are attached to hydraulic legs. These hydraulic legs are coupled with an intelligent stability control system, which ensures a level cargo platform even on rough or rugged surfaces. Thanks to its advanced sensor, it can adapt to different terrains and maintain balance. This enables the KATR to run flawlessly in environments like agricultural fields and construction sites, reports NewAtlas.
‍
A feature that makes it standout is its dual power system. It allows the KATR to operate on either an electric motor or a diesel engine, depending on the choice of the user. The electric motor is eco-friendly but produces less power. The diesel engine produces high power which allows it to do more heavy-duty tasks.
‍
Related Optimus Robots Could Make Tesla a $25 Trillion Company
‍
It has a load capacity of 284 pounds (129 kg), which makes it practical for transporting heavy materials in remote or difficult to access locations. The KATR can work in hazardous zones reducing the risk of human lives, also its compact design helps it to operate efficiently even in tight spaces.
‍
The Kubota KATR’s revolutionary approach to terrain navigation earned it the “Best of Innovation” title at CES 2025. Their commitment to integrating robotics in our everyday life is evident in this design.
‍
Kubota says that it has plans to start leasing the KATR in Japanese markets next year, for a cost of 1,980 yen (about $13) an hour. They are still not sure when they will enter the Global market.
‍
In the world of Robotics, the KATR is more than just a technological marvel; it represents an autonomous solution for industries needing heavy-duty machineries in challenging terrains. This robot is set to redefine safety and efficiency through its innovative design, adaptability, and durability. It offers a future where robots can increase productivity while reducing the strain on human labor.

Medical device innovator, PhotoniCare has achieved a major milestone by signing a manufacturing partnership with Gentex Corporation and raising $4.6 million in a Series B funding round. PhotoniCare’s flagship product, OtoSight Middle Ear Scope is the center of this collaboration. It is an advanced diagnostic tool used for middle ear infection.
‍
The OtoSight Middle Ear Scope uses the latest technologies to diagnose middle ear infections. It features OCT for high-resolution images, enabling the detection and characterization of fluid in the ear with up to 90.6% accuracy. It is the first FDA-cleared device of its kind and has benefited more than 26,000 patients. It created unique revenue opportunities for providers through dedicated CPT codes.
‍
Gentex expects a capital raise of almost $9 million. It will manufacture OtoSight devices in Zeeland & Michigan, which will support PhotoniCare’s plans to scale operations, expand sales, & complete ongoing clinical trials. This partnership also reflects Gentex’s strategy to get into medical technology alongside its traditional expertise in automotive systems.
‍
Related Solar Panels in Your Eyeballs to Restore Vision
‍
PhotoniCare has planned to relocate its headquarters from Champaign, Illinois to Grand Rapids, Michigan, to work closely with Gentex. This will help them get support from local investors like the Michigan Capital Network, which will help PhotoniCare to get into the state’s growing medical technology ecosystem.
‍
In 9 years, PhotoniCare has raised over $17 million in private capital and over $6 million in federal grants. Having created strong credibility in the healthcare market, after partnering with Gentex, PhotoniCare is expected to pave the way for new generations of diagnostic devices.
‍
With a proven track record and promising future, PhotoniCare continues to lead innovation in health diagnostics and set a benchmark in pediatric and general healthcare.

One of the most potential markets for printed and flexible electronics is healthcare. For instance, a bandage is naturally flexible, but because it has been demonstrated that an electric field can aid in the healing of chronic wounds, it would be a major advancement if it were possible to generate an electric current to encourage the healing process.
‍
Getting the science down is crucial for healthcare approvals, so that's one of the challenges. At the top of the list is creating a product that is affordable, reports David Savastano in Printed Electronics.
‍
Researchers from all over the world are trying to find potential solutions because this might be a big advancement in the treatment of wounds. North Carolina State University is leading one such research team that is making strides in this technology in collaboration with Beth Israel Deaconess Center, Columbia University, and researchers from other institutions and institutes. North Carolina State University and the Defense Advanced Research Projects Agency (DARPA) provided funding for the study.
‍
The high expense of treating chronic wounds is a significant problem, according to Amay Bandodkar, co-corresponding author of the study and an assistant professor of electrical and computer engineering at North Carolina State University.
‍
“Chronic wounds are a major health problem that affects millions of individuals each year,” said Bandodkar, who along with Rajaram Kaveti, co-first author of the study and a post-doctoral researcher at NC State, are inventors on a patent application related to this work. “The cost for treating chronic wounds is exorbitantly high. It costs several thousands of dollars to treat one chronic wound in the US. We wanted to explore if our prior experience in wearables and biocompatible batteries could be adapted to develop low-cost treatments.”
‍
Related This Smart Bandage Provides Wound Report in Real-Time
‍
One side of these water-powered, electronics-free dressings (WPEDs) is printed with electrodes, and the other side is printed with a tiny, biocompatible battery. The patient is dressed in a way that allows the electrodes to touch the wound. The battery is then activated by applying a drop of water to it. The disposable bandage creates an electric field for a few hours after it is activated.
‍
“That electric field is critical, because it’s well established that electric fields accelerate healing in chronic wounds,” said Kaveti.
‍
Each of the partners is bringing their expertise to the project. The Beth Israel Deaconess Center contributed clinical information, Columbia University carried out the animal studies, and North Carolina State created the bandages. Experts from Korea University, Georgia Tech, the Korea Institute of Science and Technology, and the combined biomedical engineering department at NC State and the University of North Carolina at Chapel Hill are also part of the research team. They helped with computer simulations.
‍
Bandodkar reported that the recent findings have been promising. The researchers tested the dressings on diabetic mice, finding that the wounds healed approximately 30% faster than wounds that were treated with only occlusive dressings (same as the ones you find in your local store).
“We were excited to see that our hypothesis that electronics-free, low-cost dressings could provide accelerated healing comparable to treatments that rely on expensive biological agents,” said Bandodkar.
‍
“This collaborative project shows that these lightweight bandages, which can provide electrical stimulation simply by adding water, healed wounds faster than the control, at a similar rate as bulkier and more expensive wound treatment,” said Sam Sia, co-corresponding author of the work and professor of biomedical engineering at Columbia University, when the initial paper was published.
‍
Ultimately, this system will need to advance to clinical trials. However, the next step is to test the bandages on pigs.

Elon Musk's Neuralink said it has received approval to launch a new feasibility study using its brain implant and an experimental robotic arm.
‍
Neuralink is conducting its PRIME study, aimed at evaluating the safety of its wireless brain-computer interface and surgical robot. It is assessing the initial effect of the implant in patients with quadriplegia, a form of paralysis, to control external devices with their thoughts.
‍
"This is an important first step towards restoring not only digital freedom, but also physical freedom. More info to come, but the CONVOY Study will enable cross-enrolling participants from the ongoing PRIME Study," Neuralink said in a post.
‍
The PRIME study (Precise Robotically Implanted Brain-Computer Interface) involves the placement of a small, cosmetically invisible implant in the area of a person's brain that plans movements. The N1 implant is designed to interpret one's neural activity to assist them in operating a computer or smartphone by simply intending to move, reports MobiHealthNews.
‍
The company is still looking for people to contribute to the ongoing medical device clinical trial, which aims to enable people with quadriplegia to utilize digital gadgets with their thoughts.
‍
In February, 29-year-old quadriplegic Noland Arbaugh received the first implant of Neurolink's BCI device, which allowed him to play video games and chess hands-free.

Related Neuralink's "Blindsight" Gets FDA Nod to Restore Vision
‍
Health Canada, the company's regulator, gave the company permission last week to begin a device trial in Canada. The firm and Canadian neurosurgeons have received regulatory approval to enlist six paralyzed individuals in the research.
‍
Neuralink has already implanted the device in two people in the United States. The first patient has been able to use it to move a cursor on his laptop, play video games, access the internet, and post on social media.
‍
The company said the second trial patient has been using the device to play video games and learn how to construct 3D items, and it is functioning effectively.

Movano Health, a pioneer in health technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the pulse oximeter in its EvieMED Ring. The clearance enables Movano Health to pursue multi-billion-dollar business opportunities for health monitoring solutions needed for applications such as clinical trials, post-clinical trial management, and remote patient monitoring for both healthcare providers and payors.
‍
"We launched the Evie Ring in the consumer wearable market, but our broader goal has always been to provide a clinical-grade device for B2B channels," said John Mastrototaro, President and CEO of Movano Health. "This FDA 510(k) clearance marks a major milestone for the Company and expands our reach to pharmaceutical companies, medical device manufacturers and payors looking for a more accurate, consistent and comfortable health monitoring solution that would help improve compliance by fitting easily into patient lifestyles."
‍
In anticipation of an expected 510(k) clearance, Movano Health has been collaborating with a number of potential partners operating across the entire healthcare industry spectrum and expects its partner pipeline to expand further following the news of a clearance. The Company is currently in the agreement phase with a large payor for a pilot study with the EvieMED Ring planned for early 2025 related to the health management of high-risk populations and is also in discussions with a global pharmaceutical company and leading clinical research organization (CRO) to use the EvieMED Ring in upcoming clinical trials. In addition, the EvieMED Ring was recently selected for a groundbreaking MIT study on long COVID and chronic Lyme disease, the company said in a press release.
‍
"This milestone marks the beginning of our plans to accelerate distribution of EvieMED. With the significant foundational work in achieving our first clearance now behind us, we are eager to continue to collaborate with the FDA on securing additional clearances including respiration rate and other critical analytes and diagnoses," continued Mastrototaro. "We also remain excited about the opportunities to leverage our proprietary radio frequency (RF) technology to address cuffless blood pressure and noninvasive glucose monitoring."
‍
Related FDA Clearance for a New Smart Ring
‍
Pulse oximeters measure blood oxygen (SpO2) levels and heart rate, but conventional solutions have significant shortcomings and can be uncomfortable, discouraging compliance that is needed to ensure reliable information for evaluating a patient's health. The EvieMED Ring eliminates those limitations by combining the accuracy of a medical device with the comfort of a wearable that can be worn continuously, thanks in part to an award-winning design with a small gap in the ring surface and slight flex that accommodates finger swelling. A pivotal study also found that the EvieMED Ring produces accurate readings among users with darker skin tones as measured by the Fitzpatrick scale of skin color classification.
‍
In addition, the EvieMED Ring collects wellness metrics including sleep, activity, temperature variability, calories burned and respiration rate that can give both patients and healthcare providers a broader picture of the user's overall wellness.
‍
The EvieMED Ring will be available in eight sizes ranging from 5 to 12 to accommodate the widest selection of patients.
‍
About Movano Health
‍
Founded in 2018, Movano Health is developing a suite of purpose-driven healthcare solutions to bring medical-grade data to the forefront of wearables. Featuring modern and flexible form factors, Movano Health's devices offer an innovative approach to delivering trusted data to both customers and enterprises, capturing a comprehensive picture of an individual's health data and uniquely translating it into personalized and intelligent insights.

Imagine wearing a sunglass and being able to adjust the tint level according to one’s own liking, adjusting for the right tint that brings perfect visibility in any lighting condition. Lombell’s Adjustable-Tint Sunglasses allows you to do exactly that. Their innovative design and functionality have made these sunglasses quite popular.
‍
Combining both, advanced technology and stylish aesthetics, these sunglasses are equipped with built-in Neutral Density (ND) filters, that will enable the users to adjust the tint level across nine different settings, simply by twisting the lens frame. This was inspired by professional photography equipment, reports New Atlas.
‍
Key Features

• These sunglasses provide nine levels of tint. It allows users to seamlessly transition between different tint levels through a one-hand rotary adjustment system.
• They feature premium Polaroid lenses with UV400 protection, ensuring clear vision while also blocking harmful UV rays. This reduces eye strain and make them suitable for prolonged use.
• Made from titanium alloy, the frame is both lightweight and robust. It ensures all day comfort without compromising durability.
• Being very stylish & versatile, they complement a variety of outfits. Some even describe them as the “Swiss Army Knife of shades” for their adaptability & unique looks.

Related World’s First Emotion-Sensing Smart Glasses
‍
Lombell’s sunglasses were made to fulfill a variety of needs. From outdoor enthusiasts & travelers, to everyday users, all have praised these glasses. It’s ability to reduce eye strain & enhance comfort during activities like driving or hiking made it a favorite among all. However, some users said that minor design improvements could enhance their usability, like better nose grip or ear hooks.
‍
Currently, Lombell’s Adjustable-Tint Sunglasses are available on sale for $89.99, down from their regular price of $129.99. It includes free express shipping and a 30-day return policy. It also provides a one-year warranty for peace of mind of the buyers. These make Lombell’s sunglasses a competitive choice in the premium eyewear market.
‍
Lombell’s Adjustable-Tint Sunglasses are a major leap forward in eyewear innovation. It blends practicality, protection, & fashion, all into one single accessory. These sunglasses ensure that you see the world in perfect light.

Clim8 is a company pioneering a new approach to heated apparel with its innovative Clim8® technology. This smart heating system goes beyond simple on/off functionality, offering a personalized and efficient heating experience controlled via a dedicated app.

Clim8® technology utilizes multiple sensors embedded within the garment itself. These sensors continuously monitor the wearer's profile (likely including factors like age, gender, and typical activity levels), current activity (e.g., sitting, walking, skiing), and ambient temperature. This real-time data is then processed by a sophisticated algorithm that dynamically adjusts the heating output to maintain optimal comfort.

Key features and benefits of Clim8® technology include:

• ‍Smart Heating: The system intelligently regulates heat in real-time, adapting to changes in the wearer's environment and activity level. This ensures consistent comfort without manual adjustments.‍
• Automatic Power On/Off: Clim8® automatically activates and deactivates the heating elements based on usage, preventing unnecessary battery drain and maximizing efficiency.‍
• Smart Battery Usage: The technology is designed for optimal energy consumption, extending battery life and allowing for longer periods of use.‍
• Lab and Field Tested: Clim8® products undergo rigorous testing in both laboratory and real-world field trials to ensure thermal performance, durability, and reliability. This commitment to testing underscores the company's focus on delivering a high-quality product.‍
• App Control and Personalization: The Clim8® app is central to the user experience. It allows users to control temperature settings, personalize their heating preferences, and provide feedback to the company. This feedback loop contributes to the system's ongoing learning and improvement, further refining the personalized heating experience.

Clim8® aims to provide a truly tailored heating experience, moving away from traditional, static heating solutions. By combining sensor technology, intelligent algorithms, and user-friendly app control, Clim8 SAS is positioning itself as a leader in the next generation of heated apparel.

‍

About Clim8

Clim8 was founded in 2016 by three entrepreneurs who shared a vision of creating the best thermo-regulating clothing. In addition to winning multiple awards, Clim8 has collaborated with leading brands to bring its products to market and continues to develop new product lines and expand its global reach.

South Korean researchers have developed an AI-based tool that can predict episodes of mood disorder in patients using only sleep-wake data recorded by wearable devices such as smartwatches. People suffering from mood disorders, including bipolar disorder, experience long periods of sadness, depression, joy or mania. Mood disorders are closely linked with sleep-wake rhythms with disturbances potentially triggering a mood episode.
‍
The team comprised researchers from the Institute for Basic Sciences (IBS), Korea Advanced Institute of Science and Technology (KAIST), and Korea University College of Medicine.
‍
First, 168 Korean patients with mood disorders, including major depression and bipolar disorder, had their Fitbit sleep-wake data gathered and analyzed for 429 days. It is said that irregular sleep and circadian rhythms are intimately linked to mood problems, reports MobiHealthNews.
‍
In order to train models based on the machine learning package XGBoost to predict mood episodes, scientists took 36 sleep and circadian rhythm parameters out of this dataset.
‍
According to the results, the predictive models were able to predict depressive, manic, and hypomanic episodes with 80%, 98%, and 95% accuracy, respectively.
‍
Related Researchers Deploy Machine Learning to Improve Mental Health
‍
Findings also suggested that daily changes in circadian rhythm may be a key predictor of mood episodes; delayed circadian rhythms can potentially lead to depressive episodes while advanced circadian rhythms can raise the possibility of manic episodes.

‍
Although AI models for forecasting the emotional states of individuals with mood disorders already exist, they usually require a variety of data, such as GPS, sleep, heart rate, light exposure, and phone usage, all of which can be expensive to gather. The research team emphasized that it might also provide storage issues as well as security and privacy problems.
‍
"By developing a model that predicts mood episodes based solely on sleep-wake pattern data, we have reduced the cost of data collection and significantly improved clinical applicability," claimed Kim Jae Kyoung, KAIST associate professor and IBS chief investigator.
‍
The research team also highlights the possibility of using digital treatments in conjunction with mood state prediction to assess the daily risk of relapsing mood episodes and encourage healthy circadian rhythms and sleep-wake cycles by sending out reminders.
‍
The study was published in Nature's npj Digital Medicine journal.

Epicore Biosystems, a digital health solutions company developing advanced sweat-sensing wearables, announced that it has inked a 3-year master services agreement (MSA) with Chevron Technical Center, a division of Chevron U.S.A. Inc. to equip Chevron's industrial frontline workers with its Connected Hydration solution. The first deployments are expected to begin in the US in the summer of 2024.
‍
This milestone MSA marks a pivotal moment for Epicore on the heels of several field deployments with Chevron and other enterprises. The Chevron health and safety teams have deployed Epicore's Connected Hydration solution across multiple work sites and conditions over the past two years, leading to its commercial launch in April 2024. Chevron Technology Ventures also invested in Epicore to support the development and commercialization of Connected Hydration, the company said in a press release.
‍
Connected Hydration is a sweat-sensing wearable biosensor and cloud analytics solution that measures sweat loss, sodium loss, skin temperature, and movement to provide actionable rehydration strategies in real time to industrial workers ahead of adverse dehydration events. The technology enables workers to quantify hydration biomarkers and create actionable routes to rehydration and recovery for industrial workers. Epicore's Connected Hydration solution is a proven sweat-sensing technology that provides individualized rehydration strategies and real-time haptic vibration alarms felt by the workers to proactively inform them to stay safe and hydrate.
‍
Related How Augmented Reality Is Helping Workers In The Cement Industry
‍
"We have spent years developing, validating and deploying Connected Hydration. A master service agreement with a large enterprise like Chevron is a testament to how Epicore Biosystems is bridging the global gap in worker safety when it comes to proper hydration and heat stress solutions," said Dr. Roozbeh Ghaffari, CEO and co-founder of Epicore Biosystems. "We are honored to work with Chevron as one of our first customers and to deploy Connected Hydration, enabling tailored and preventative hydration practices for their frontline workers. The reality is that a conventional, one-size-fits-all approach to heat index tracking falls short in meeting workers' hydration and recovery needs."
‍
Chevron compiled datasets from over a thousand sweat sessions in total across multiple work sites in the U.S. to explore how behavioral changes take shape when workers utilize Connected Hydration compared to conventional approaches. Health and safety experts along with industrial hygienists observed that Connected Hydration informed and improved hydration habits significantly by increasing worker fluid and electrolyte intake over a one-month time window, via real-time awareness of fluid and electrolyte losses. This sustained change in behavior in response to rehydration feedback was rapid and took place within a few weeks of Connected Hydration use.
‍
"The entrepreneurial ecosystem's speed, together with the know-how of incumbents - that's a very powerful combination," said Jim Gable, VP of Innovation and President of Technology Ventures for Chevron. "In this case, Chevron and Epicore were able to leverage thousands of work session datasets across multiple sites to enhance the impact of the Connected Hydration technology to keep our employees safe."
‍
Since its launch in 2017, Epicore has lined up several global collaborators and customers. These enterprises include Chevron, PepsiCo, Denka, Gatorade, Fluor, Nitto, the U.S. Air Force, Office of Naval Research, Army and more.
‍
About Epicore Biosystems
‍
Founded in 2017, Epicore Biosystems is a digital health company developing advanced sweat-sensing wearables that provide real-time personalized health insights for hydration, stress and wellness. Their clinically validated biowearable products and cloud analytics are deployed globally and licensed by leading Fortune 500 companies, the Department of Defense and the National Institute of Health.

In a market increasingly saturated with wearables, Noise's Luna Ring stands out with its slim, minimalist design and an intriguing blend of fitness tracking features. While smart rings have been around for a few years, Noise’s entry into this space is particularly notable for its development right in India.

Let’s dive into what makes the Luna Ring an interesting choice for those looking to upgrade their tech accessories without sacrificing style or comfort.

A tailored approach to sizing and fit

Unlike most fitness bands and smartwatches, the Luna Ring requires a precise fit, as resizing is not a DIY task. To make this process easier, Noise offers a sizing kit to help users select the perfect ring size. Though Noise suggests wearing the ring on the index finger, users frequently switch it between index and middle finger, depending on comfort.

A design to admire‍

Measuring just 2.8 mm in thickness, the Luna Ring’s slim design gives it a sleek, unobtrusive appearance that’s both functional and stylish. Available in Stardust Silver, Lunar Black, and Midnight Black, it caters to a variety of tastes while maintaining a high-end, understated aesthetic. Beneath its elegant exterior lies a range of sensors integrated into a flexible circuit board, all housed in a waterproof casing. While the idea of a smart ring isn’t entirely new, the Luna Ring brings a refreshing, locally designed alternative to the table.

Seamless setup and interface

Getting started with the Luna Ring is simple. Upon placing it on its charging dock, the ring quickly pairs with the companion app on your smartphone. The setup process is straightforward, with the app requesting basic details such as your weight, height, and gender to personalize your health metrics. Once paired, the app offers an easy-to-navigate interface, with key information like activity levels, sleep scores, and readiness all clearly displayed.

Health and fitness tracking is smart yet subtle

The Luna Ring's key selling point is its ability to monitor your health without being intrusive. As someone who typically avoids wearing a fitness tracker to bed, the Luna Ring’s sleep tracking feature was a revelation. It effortlessly detects sleep patterns, breaking down nightly rest into various stages, including deep sleep, REM, and light sleep. It also gives insights into sleep efficiency and latency, which allows users to understand how restful their sleep truly was.In addition to sleep, the ring tracks your daily activity and provides a Readiness Score to gauge how prepared you are for the day. This score takes into account both your activity levels and sleep quality over the past few days, offering an at-a-glance measure of your overall readiness.

Tracking activity step counts and more‍

While the Luna Ring automatically tracks steps and heart rate, it doesn't automatically detect specific activities like running or cycling. For these, users have to manually enter workout details into the app, such as the duration, intensity, and type of activity.

When it comes to battery life, the ring is longevity on your finger‍

The Luna Ring even after three full days of use, still has about 14% of its charge left. The charging dock is simple to use, though it doesn’t come with a power adapter—any standard USB adapter will work. The ring takes roughly an hour to charge completely, making it a low-maintenance device in terms of power.

Noise’s debut in the smart ring market with the Luna Ring is an impressive one. Its minimalistic design and intuitive tracking features make it an appealing option for those looking for a smart wearable that doesn’t compromise on style or comfort. Whether it’s accurate sleep tracking, the convenience of a readiness score, or the solid battery life, the Luna Ring proves itself to be a functional, stylish choice for health-conscious individuals.

Investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, evaluated whether data collected from a fitness tracker could be used to accurately detect mood episodes in people with bipolar disorder.
‍
They used fitness tracker Fitbit data to train a machine learning algorithm to accurately predict mood episodes associated with bipolar disorder.
‍
Their findings, published in Acta Psychiatrica Scandinavica, indicate that it is possible to detect time intervals when patients with bipolar disorder are experiencing depression or mania with high accuracy using data from fitness tracking devices, reports ScienceDaily.
‍
"Most people are walking around with personal digital devices like smartphones and smartwatches that capture day-to-day data that could inform psychiatric treatment. Our goal was to use that data to identify when study participants diagnosed with bipolar disorder were experiencing mood episodes," said corresponding author Jessica Lipschitz, PhD, an investigator in the Brigham's Department of Psychiatry.
‍
Related Fitbit Gets US FDA Approval For Detecting AFib
‍
"In the future, our hope is that machine learning algorithms like ours could help patients' treatment teams respond fast to new or unremitting episodes in order to limit negative impact."
‍
Bipolar disorder (BD) is a chronic psychiatric disorder characterized by extreme mood swings, including depression, mania, and hypomania followed by periods of remission.
‍
Identification and treatment of new and unremitting mood episodes is essential for limiting the impact of BD on patients' lives.
‍
While previous research has indicated that personal digital devices can accurately detect mood episodes, previous studies have not used methods designed for broad application in clinical settings.
‍
As an implementation scientist, Lipschitz, together with colleagues, focused on using methods that could be broadly implemented in clinical practice.
‍
Specifically, they used commercially available personal digital devices, limited data filtering, and entirely passively collected and noninvasive data.
‍
Applying a new type of machine learning algorithm, they were able to detect clinically significant symptoms of depression with 80.1% accuracy and clinically significant symptoms of mania with 89.1% accuracy.
‍
The researchers note that, "overall, results move the field a step toward personalized algorithms suitable for the full population of patients, rather than only those with high compliance, access to specialized devices, or willingness to share invasive data." Their next step is to apply these predictive algorithms in routine care where they could be used to improve BD treatment by informing clinicians when their patients are experiencing depressive or manic episodes between scheduled appointments. The researchers have also been working on extending this work to major depressive disorder.

Northwestern University researchers have developed a new thin, wireless system that adds a sense of touch to any virtual reality (VR) experience. Not only does this platform potentially add new dimensions to our long-distance relationships and entertainment, the technology also provides prosthetics with sensory feedback and imparts telemedicine with a human touch.
‍
Referred to as an “epidermal VR” system, the device communicates touch through a fast, programmable array of miniature vibrating actuators embedded into a thin, soft, flexible material. The 15-centimeter-by-15-centimeter sheet-like prototypes comfortably laminate onto the curved surfaces of the skin without bulky batteries and cumbersome wires, reports Amanda Morris in Northwestern University.
‍
“People have contemplated this overall concept in the past, but without a clear basis for a realistic technology with the right set of characteristics or the proper form of scalability. Past designs involve manual assemblies of actuators, wires, batteries and combined internal and external control hardware,” said Northwestern’s John A. Rogers, a bioelectronics pioneer. “We leveraged our knowledge in stretchable electronics and wireless power transfer to put together a superior collection of components, including miniaturized actuators, in an advanced architecture designed as a skin-interfaced wearable device — with almost no encumbrances on the user. We feel that it’s a good starting point that will scale naturally to full-body systems and hundreds or thousands of discrete, programmable actuators.”
‍
Related Performance Challenges in Skin-Interfaced Electronics
‍
“We are expanding the boundaries and capabilities of virtual and augmented reality,” said Northwestern’s Yonggang Huang, who co-led the research with Rogers. “By comparison to the eyes and the ears, the skin is a relatively underexplored sensory interface that could significantly enhance experiences.”
The research will be published on Nov. 21 in the journal Nature.
‍
How it works
‍
The patch wirelessly connects to a touchscreen interface (on a smartphone or tablet). When a user touches the touchscreen, that pattern of touch transmits to the patch. If the user draws an “X” pattern on the touchscreen, for example, the devices produce a sensory pattern, simultaneously and in real-time, in the shape of an “X” through the vibratory interface to the skin.
‍
When video chatting from different locations, friends and family members can reach out and virtually touch each other — with negligible time delay and with pressures and patterns that can be controlled through the touchscreen interface.
‍
“You could imagine that sensing virtual touch while on a video call with your family may become ubiquitous in the foreseeable future,” Huang said.
‍
The actuators are embedded into an intrinsically soft and slightly tacky silicone polymer that adheres to the skin without tape or straps. Wireless and battery-free, the device communicates through near-field communication (NFC) protocols, the same technology used in smart phones for electronic payments.
‍
“With this wireless power delivery scheme, we completely avoid the need for batteries, with their weight, size, bulk and limited operating lifetimes,” Rogers said. “The result is a thin, lightweight system that can be worn and used without constraint, indefinitely.”
‍
‘A starting point’
‍
Rogers views the current device as a starting point. “This is our first attempt at a system of this type,” he said. “It could be very powerful for social interactions, clinical medicine and applications that we cannot conceive of today, beyond the obvious opportunities in gaming and entertainment.”
‍
He and Huang are already working to make the current device slimmer and lighter. They also plan to exploit different types of actuators, including those that can produce heating and stretching sensations. With thermal inputs, for example, a person might be able to sense how hot a cup of coffee is through prosthetic fingertips.
The Northwestern team believes the overall engineering framework can accommodate hundreds of actuators with dimensions significantly smaller than those used currently, which have diameters of 18 millimeters and thicknesses of 2.5 millimeters.
‍
Eventually, the devices could be thin and flexible enough to be woven into clothes. People with prosthetics could wear VR shirts that communicate touch through their fingertips. And along with VR headsets, gamers could wear full VR suits to become fully immersed into fantastical landscapes.
‍
“Virtual reality is a very important emerging area of technology,” Rogers said. “Currently, we’re just using our eyes and our ears as the basis for those experiences. The community has been comparatively slow to exploit the body’s largest organ: the skin. Our sense of touch provides the most profound, deepest, emotional connection between people.”

Singapore's Health Promotion Board has partnered with several technology companies to pilot program that aim to promote self-health management by delivering data-driven, personalized recommendations for preventing and managing chronic diseases.
‍
Despite having one of the longest life expectancies in the world, Singapore faces a unique combination of difficulties. The healthcare system and public health are seriously threatened by the rising incidence of chronic illnesses. About 1 in 9 Singaporeans who are 18 years of age or older have diabetes, and the percentage is predicted to increase, according to the Ministry of Health. Furthermore, the nation's biggest cause of mortality is cardiovascular disease.
‍
Pre-diabetic people or those with a high body mass index will be the focus of Abbott's DigiCoach initiative in collaboration with Health2Sync, a Taiwanese company that develops a digital diabetes platform, reports Healthcare IT News.
‍
In order to give customers near real-time information and help them understand how their blood glucose levels impact their diet and physical activity, it incorporates Abbott's FreeStyle Libre continuous glucose monitor, which will be coupled with Health2Sync's mobile app. Furthermore, the program's digital coaching component will help pilot participants modify their lifestyles to better control their blood sugar.
‍
HealthTrack SG, another initiative with Google, will help users manage hyperlipidemia, diabetes mellitus, or hypertension.
‍
Related Singapore Wearables Startup Raises $5 Million
‍
The program will use Fitbit fitness trackers to gather clinical data, such as blood pressure, cholesterol, and blood sugar levels, as well as lifestyle data, such as step count, physical activity level, and sleep quality, in collaboration with Fullerton Health and digital health tech company ConnectedLife. Google and ConnectedLife will combine these data into an online dashboard for physicians and incorporate it into a companion mobile application.
‍
Additionally, the mobile app will offer advice and prods to help users make lifestyle changes that have been approved by Fullerton Health physicians.
In order to assist Singaporeans take greater control of their health, the HPB, which oversees the country's national health promotion and disease prevention initiatives, has looked to industry partnerships to test out innovative ideas.
‍
Up to 6,000 Singaporeans are anticipated to participate in the agency's most recent pilot programs, according to a statement. Sign-up for the 10-month DigiCoach by Abbott and Health2Sync program started in July, and the Google-ConnectedLife project, which will last for a year, will begin in the first half of 2025.
‍
These programs are also expected to provide HPB data-driven insights into the health concerns and lifestyle risks of Singaporean people. "All data collected will be protected and stored according to Singapore’s data privacy and security laws," it assured.
‍
Additionally, HPB is exploring the potential to scale the programs to more Singaporeans once proven effective and feasible.

XREAL unveiled a step change for its newest augmented reality (AR) glasses, XREAL One Series, that the company believes is the biggest leap forward for the consumer AR industry and advances its mission to bring AR to everyone. Using XREAL's brand new, in-house designed X1 independent spatial computing co-processor, XREAL One Series creates a spatial display from nearly any device and for anything the wearer sees, leaping beyond the limits of today's AR and VR devices by introducing a fully customizable cinematic virtual screen that is for the first time spatially controlled by the glasses themselves. XREAL One Series connects to nearly any compute device with video over USB-C, unlocking a spatial display for unlimited apps, games, web sites, productivity tools, communications platforms, and more, while also enabling AR holographic experiences from developers who build with XREAL's SDK.
‍
XREAL One Series consists of XREAL One and XREAL One Pro, and are the first cinematic AR glasses, wearable displays, or smart glasses to deliver native next generation three degrees-of-freedom (3DoF) spatial computing using an integrated spatial co-processing chip built directly into the glasses, XReal said in a press release.
‍
"The XREAL One Series represents the most advanced consumer AR glasses on the market today," said Chi Xu, CEO and Co-founder of XREAL. "I'm thrilled for everyone to experience the XREAL One Series and see the X1 chip in action. It's a true game-changer."
‍
Spatial Computing Anywhere with X1
‍
Any XREAL One Series wearer, no matter if they connect their XREAL One Series glasses to an iPhone, Android device, Steam Deck, Windows PC, MacBook, or just about any device with video-out over USB-C, can experience the most stable virtual screen and anchor it anywhere they choose in three-dimensional space with the simple press of a button on the glasses. These are AR glasses benefits previously held back by limited hardware and software configurations.
‍
Related XREAL Launches Air 2 Series AR Glasses
‍
The on-glasses customization options include: screen size, screen distance, stabilizer, side view, brightness enhancement, display optimization, color temperature, 2D/3D switching, IPD adjustment, volume and sound settings, button mapping settings, sensor calibration, language settings, tutorial and factory reset. The XREAL One Series also features Ultra-Wide Mode viewing with a 32:9 aspect ratio, perfect for productivity and some gaming experiences.
‍
Bigger Displays, Expanded IPDs, Eye Comfort, and Thinner Frames
‍
XREAL One Pro achieves a big industry first by creating the first flat-prism lens design, a change from the traditional triangular birdbath design, and reaching an industry-leading 57-degree FOV. This is an 11mm thin plane that's 40.9% thinner than traditional birdbath optics and increases the FOV by 23.9% compared to the XREAL Air 2 Series and which produces a 63.6% larger display area than the XREAL Air 2 series.
‍
The glasses' temples include a 4-microphone layout with exclusive near-field and far-field algorithms that capture clear recordings of both near and distant voices. This can enable audio recording for meeting summaries, transcriptions and translations, or empower other recording scenarios.
‍
Advanced Audio Options with Sound by Bose
‍
XREAL One and XREAL One Pro incorporate customized Sound by Bose, delivering audio that is meticulously fine-tuned for XREAL One Series and providing significantly enhanced listening experiences when compared to similar head worn or mobile devices.
‍
XREAL Eye Camera
‍
The XREAL One Series supports an optional and modular RGB camera called XREAL Eye, a first-of-its-kind detachable accessory that captures real-time 12MP high-definition photos and smooth HD video recording at up to 1080p at 60fps. XREAL Eye can be activated by the touch of a button on the temple of the glasses.
‍
Pricing and Availability
‍
XREAL One is available for pre-orders now for $499 USD, £449 GBP, €549 Euro through XREAL.com and XREAL's Amazon store. XREAL One Pro is available for pre-orders now for $599 USD, £549 GBP, €649 Euro through XREAL.com. XREAL One is expected to begin shipping to customers in mid-December and XREAL One Pro is expected to ship to customers in early 2025. Bundles will be available with XREAL One or XREAL One Pro plus XREAL Beam Pro.

Cala Health, the non-invasive bioelectronic medicine maker, announced it has completed the initial closing of an oversubscribed $50 million growth round, co-led by Vertex Growth Fund and Nexus NeuroTech Ventures. All existing Cala investors participated in the round, including Action Potential, Johnson & Johnson (through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc.), Lightstone, Lux Capital, GV (Google Ventures), OSF Ventures, Ascension Ventures, TriVentures, Reimagined Ventures, Peak6 and Fiscus.
‍
Related Cala Health's Neurostimulation System Treats Parkinson's
‍
"This round of funding will propel Cala's commercialization trajectory, notably with the recent positive Medicare Coverage Determination for Cala TAPS (Transcutaneous Afferent Patterned Stimulation) Therapy. It allows us to broaden patient and physician awareness of this effective and innovative treatment," said Deanna Harshbarger, Cala Chief Executive Officer. "We are very excited about the strong support from both our legacy and new investors who believe in our vision and first in class, on-demand technology to address tremor relief."
‍
Cala is continuing to build strong clinical evidence to expand patient access for our neurostimulation therapy. The results of a study by CVS Health, presented at the Movement Disorders Congress this year, concluded that TAPS therapy offers substantial benefits for patients with essential tremor (ET) in reducing ET-related healthcare resource utilization (HCRU), healthcare costs and improving clinical outcomes, says a press release.
‍
ET impacts over 7 million people in the United States and is characterized by uncontrollable movement that can make critical daily activities very difficult. Drugs are most used to treat ET, but they can cause a range of unwanted side effects such as fatigue, nausea and depression and may not provide desired outcomes. Surgical options like Deep Brain Stimulation or Focused Ultrasound ablation can be effective but are invasive procedures that carry the risk of potentially irreversible side effects.
‍
The Cala kIQ System with TAPS Therapy is the only non-invasive, FDA-cleared, wearable device that delivers effective therapy for action hand tremor relief in people with essential tremor and Parkinson's disease. The TAPS device is clinician-prescribed and clinically proven to safely and effectively reduce action hand tremors. The Cala kIQ device treats tremor by sensing each patient's unique tremor signature and delivering individualized stimulation to the nerves on the wrist that then reach the brain to counteract tremor.
‍
About Cala Health
‍
Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, and its direct-to-home digital durable medical equipment (DME) platform is reshaping the delivery of prescription therapies.

Immersive therapeutic solutions provider XRHealth launched its groundbreaking AI-powered medical XR platform. This release marks a major milestone in the integration of cutting-edge AI technologies within a comprehensive therapeutic system.

The newly launched platform features an advanced multi-space capability, allowing clinicians to seamlessly transition between various therapeutic environments for optimized treatment outcomes. At the heart of this innovation is the AI Generator Space, which enables the creation of custom 360-degree environments tailored to individual therapeutic needs. In addition, a groundbreaking new feature allows for the generation of dynamic avatars, utilizing AI and XR to further enhance patient interaction and personalization, XRHealth says in a press release.
‍
"Our new AI-powered platform represents a transformative step in healthcare technology," said Eran Orr, CEO of XRHealth. "By combining artificial intelligence with immersive XR experiences, we're enabling clinicians to create tailored, interactive therapeutic environments that adapt to each patient's unique needs. This platform not only improves patient engagement but also has the potential to significantly elevate clinical outcomes across a wide range of treatments."

Related How AI and XR Industry Is Serving Millions

In addition to the AI Generator Space, XRHealth is incorporating AI into three other critical areas of its platform:

• AI Treatment Search – Delivers targeted recommendations by identifying the most relevant environments for specific conditions.
• AI Reports Analysis – Automatically generates detailed insights from therapy sessions by comparing real-time data with patient history, past interactions, and industry benchmarks.
• AI Treatment Plan – Provides clinicians with personalized treatment suggestions based on comprehensive data analysis, improving therapeutic strategies and patient outcomes.

Designed for a wide range of medical applications, including physical therapy, cognitive rehabilitation, pain management, and mental health, this multidisciplinary solution empowers clinicians with an AI-driven toolkit to enhance patient engagement, increase efficiency, and drive better clinical outcomes.

About XRHealth
‍
XRHealth is a pioneering company in the development of immersive therapeutic solutions, leveraging VR and XR technologies to revolutionize healthcare. The XRHealth platform empowers clinicians with personalized treatment plans that enhance patient engagement and improve clinical outcomes across multiple therapeutic areas. With strategic acquisitions such as Amelia Virtual Care and NeuroReality, XRHealth is on a mission to become the largest XR therapeutic platform globally, advancing the boundaries of virtual healthcare for diverse patient needs.

Los Angeles Unified School District (LAUSD) recently has partnered with Avantis Education to bring educational virtual and augmented reality (VR/AR) solution ClassVR to its students. The partnership is bringing upwards of 16 thousand ClassVR headsets to students for advanced virtual reality (VR) and augmented reality (AR) learning. This collaboration supports LAUSD’s Instructional Technology Initiative, which aims to provide students with engaging, immersive learning experiences that enhance both academic instruction and student engagement.

ClassVR is an immersive learning solution created specifically for K-12 classrooms. It offers a comprehensive package that includes all necessary hardware, software, training, and support for seamless VR/AR deployment. This service will allow the Los Angeles Unified education group to access a broad library of immersive learning tools and resources, enabling students to interact with XR lessons.  

Related A New Level of Immersion in Virtual Training

“Los Angeles Unified has demonstrated its commitment to being a pioneer in educational technology by placing students at the forefront of innovative learning tools. Through our collaboration, we’re proud to help the district expand its use of VR technology in a thoughtful, strategic way, supporting the district’s vision of making learning more engaging and future-focused,” says Huw Williams, CEO of Avantis Education.

With VR experiences that pique curiosity and encourage dynamic learning throughout the district, Avantis Education has been a valued partner of LAUSD for the past two years. ClassVR was first implemented in a small number of schools, but because to its popularity, it has quickly expanded. In order to create an engaging learning environment, many LAUSD schools now deploy ClassVR headsets in both classroom settings and extracurricular programs. Students can investigate a variety of topics, such as physics, history, and professional and technical education, using virtual reality, reports ImmersiveTechnology.

This partnership's most recent extension focuses on enrichment programs that take place before and after school and offer good chances for integration into a variety of academic subjects. This partnership demonstrates LAUSD's dedication to using immersive technology to improve student learning results and position the district as a pioneer in educational innovation.

University of Oxford researchers have made a significant step towards realizing miniature, soft batteries for use in a variety of biomedical applications, including the defibrillation and pacing of heart tissues. The work has been published today in the journal Nature Chemical Engineering.

The development of tiny smart devices, smaller than a few cubic millimeters, demands equally small power sources, reports ScienceDaily.

For minimally invasive biomedical devices that interact with biological tissues, these power sources must be fabricated from soft materials.

Ideally, these should also have features such as high capacity, biocompatibility and biodegradability, triggerable activation, and the ability to be controlled remotely.

To date, there has been no battery that can fulfil these requirements all at once.

To address these requirements, researchers from the University of Oxford's Department of Chemistry and Department of Pharmacology have developed a miniature, soft lithium-ion battery constructed from biocompatible hydrogel droplets.

Surfactant-supported assembly (assembly aided by soap-like molecules), a technique reported by the same group last year in the journal Nature, is used to connect three microscale droplets of 10 nanoliters volume.

Related Higher Performance Battery for Wearables

Different lithium-ion particles contained in each of the two ends then generate the output energy.

'Our droplet battery is light-activated, rechargeable, and biodegradable after use.

To date, it is the smallest hydrogel lithium-ion battery and has a superior energy density' said Dr Yujia Zhang (Department of Chemistry, University of Oxford), the lead researcher for the study and a starting Assistant Professor at the École Polytechnique Fédérale de Lausanne.

'We used the droplet battery to power the movement of charged molecules between synthetic cells and to control the beating and defibrillation of mouse hearts.

By including magnetic particles to control movement, the battery can also function as a mobile energy carrier.'

Proof-of-concept heart treatments were carried out in the laboratory of Professor Ming Lei (Department of Pharmacology), a senior electrophysiologist in cardiac arrhythmias.

He said: 'Cardiac arrhythmia is a leading cause of death worldwide.

Our proof-of-concept application in animal models demonstrates an exciting new avenue of wireless and biodegradable devices for the management of arrhythmias.'

Professor Hagan Bayley (Department of Chemistry), the research group leader for the study, said: 'The tiny soft lithium-ion battery is the most sophisticated in a series of microscale power packs developed by Dr Zhang and points to a fantastic future for biocompatible electronic devices that can operate under physiological conditions.'

The researchers have filed a patent application through Oxford University Innovation. They envisage that the tiny versatile battery, particularly relevant to small-scale robots for bio applications, will open up new possibilities in various areas including clinical medicine.